Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoVY: Yellow Fever Vaccine Booster Trial in Gambian Children
NCT05332197Phase 3Unknown
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Live Attenuated Vaccines
01
Overview
Phase 3, open-label trial of 17D yellow fever vaccine in yellow fever (3 cohorts), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Plaque Reduction Neutralization Test (PRNT) 50% titres. Status: unknown.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT05332197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05332197.